CIK 0001434316 · Non-accelerated filer<br>Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 651311552
- Phone
- 858.875.1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- 4 Grant or award See Remarks acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 25,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 335,000 shares (grant or award)
- 4 Open-market sale See Remarks sold 10,589 shares at $1.06 ($11,275)
- 4 Open-market sale President and CEO sold 5,190 shares at $1.07 ($5,557)
- 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale See Remarks sold 9,037 shares at $1.06 ($9,573)
- 4 Open-market sale President and CEO sold 14,466 shares at $1.06 ($15,396)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 21 · 403 filings